These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20361998)

  • 1. Fetal death as a result of placental immune reconstitution inflammatory syndrome.
    Caby F; Lemercier D; Coulomb A; Grigorescu R; Paris L; Touafek F; Carcelain G; Canestri A; Pauchard M; Katlama C; Dommergues M; Tubiana R
    J Infect; 2010 Jul; 61(2):185-8. PubMed ID: 20361998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.
    Miro JM; Lopez JC; Podzamczer D; Peña JM; Alberdi JC; Martínez E; Domingo P; Cosin J; Claramonte X; Arribas JR; Santín M; Ribera E;
    Clin Infect Dis; 2006 Jul; 43(1):79-89. PubMed ID: 16758422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery.
    Ghosn J; Paris L; Ajzenberg D; Carcelain G; Dardé ML; Tubiana R; Bossi P; Bricaire F; Katlama C
    Clin Infect Dis; 2003 Oct; 37(7):e112-4. PubMed ID: 13130422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in Thailand.
    Aramaki M; Silachamroon U; Desakorn V; Maek-A-nantawat W; Waiwaruwut J; Jutiwarakun K; Kim JH; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):138-45. PubMed ID: 20578492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
    Phillips P; Bonner S; Gataric N; Bai T; Wilcox P; Hogg R; O'Shaughnessy M; Montaner J
    Clin Infect Dis; 2005 Nov; 41(10):1483-97. PubMed ID: 16231262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment during pregnancy.
    Keiser O; Gayet-Ageron A; Rudin C; Brinkhof MW; Gremlich E; Wunder D; Drack G; Hirschel B; de Tejada BM; ;
    AIDS; 2008 Nov; 22(17):2323-30. PubMed ID: 18981771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borderline tuberculoid leprosy with upgrading Type 1 reaction in a HIV seropositive patient, after antiretroviral therapy: an immune reconstitution inflammatory syndrome.
    Kar HK; Sharma P; Bhardwaj M
    Lepr Rev; 2009 Mar; 80(1):85-8. PubMed ID: 19472856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of HIV infection: a review for non-HIV-treating physicians.
    Knoll B; Lassmann B; Temesgen Z
    Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of probable immune restoration syndrome under antiretroviral treatment in patients treated for tuberculosis in Gabon].
    Iba-Ba J; Igala M; Mipinda JB; Bignoumba Ibouili R; Eke E; Makandja R; Moubamba F; Nzamba C; Coniquet S; Moussavou Kombila JB; Boguikouma JB
    Bull Soc Pathol Exot; 2009 May; 102(2):94-6. PubMed ID: 19583029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
    Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
    AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution inflammatory syndrome in a resource-poor setting.
    Klotz SA; Aziz Mohammed A; Girmai Woldemichael M; Worku Mitku M; Handrich M
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(2):122-7. PubMed ID: 19258527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune recovery under highly active antiretroviral therapy is associated with restoration of lymphocyte proliferation and interferon-gamma production in the presence of Toxoplasma gondii antigens.
    Fournier S; Rabian C; Alberti C; Carmagnat MV; Garin JF; Charron D; Derouin F; Molina JM
    J Infect Dis; 2001 Jun; 183(11):1586-91. PubMed ID: 11343206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial.
    Miró JM; Manzardo C; Pich J; Domingo P; Ferrer E; Arribas JR; Ribera E; Arrizabalaga J; Loncá M; Cruceta A; de Lazzari E; Fuster M; Podzamczer D; Plana M; Gatell JM;
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):747-57. PubMed ID: 20624069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
    Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
    J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy.
    Tamburrini E; Ravizza M; Floridia M; Tibaldi C; Alberico S; Anzidei G; Maccabruni A; Meloni A; Antoni AD; Mori F; Dalzero S; Conservan V; Pinnetti C; Ferrazzi E;
    Antivir Ther; 2008; 13(4):519-27. PubMed ID: 18672530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.